SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate by holder12-01-2023
12-01-2023
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 ['the SEBI (DP) Regulations'] for the quarter ended December 31, 202211-01-2023
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilip Shantilal Shanghvi & PACs11-01-2023
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Intimation Of The Allotment Of Equity Shares Upon Conversion Of Warrants, Consequent To Which Shanghvi Finance Private Limited (SFPL) Has Ceased To Be The Company'S Holding Company
Consequent to the allotment, Shanghvi Finance Private Limited (SFPL) has ceased to be the Company's Holding Company as its percentage shareholding along with its subsidiaries in the Company has reduced from 52.07% to 44.37%.The number of shares held by SFPL and its subsidiaries in the Company remain unchanged06-01-2023
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Conversion of Securities
Intimation of Outcome of the meeting of the Securities Allotment Committee held today i.e. on January 06, 2023 in terms of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201506-01-2023
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of request for issue of duplicate share certificate reported by shareholder of the Company29-12-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 27, 2022 for Raksha Sudhir Valia27-12-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Closure of Trading Window
Closure of Trading Window23-12-2022